# New treatment may cure common hormonal cause of high blood pressure

> **Open Intelligence Dossier** · First detected: 2026-11-08 14:20 UTC · Category: Health

## Executive Summary
A small study found that extended treatment with the aldosterone synthase inhibitor baxdrostat led to sustained blood pressure reduction for up to two years after patients stopped taking the drug.

## Intelligence Brief
A study led by Queen Mary University of London and published in the New England Journal of Medicine found that a new treatment approach could offer a lasting cure for some people with primary aldosteronism, a hormonal cause of high blood pressure. The treatment, called extended aldosterone synthase inhibition (EASI), involves taking aldosterone synthase inhibitors such as baxdrostat for 6–12 months to target excess production of the hormone aldosterone. Unlike conventional treatments that control blood pressure, EASI appears to reverse the underlying cause, potentially removing the need for lifelong medication. Until now, a cure has required surgery to remove an entire adrenal gland.


The study followed 14 people treated at eight centers across the United States. Researchers found that EASI treatment led to sustained reversal of excess aldosterone production and partial or complete resolution of high blood pressure for up to two years after treatment ended. Hormone levels and blood pressure remained similar to, or lower than, those recorded during treatment. The main marker of excess aldosterone production remained 99% lower than before treatment, while blood pressure was, on average, 25 points lower. Almost a quarter of participants had normal blood pressure without taking any other medication.


Primary aldosteronism, in which benign nodules in the adrenal glands produce too much aldosterone, causes the kidneys to retain excess salt, raising blood pressure. It is estimated that between 5% and 10% of hypertension cases are caused by this condition. The scientific basis for EASI dates back to a 2005 experiment in mice showing that deleting the gene for aldosterone synthase caused aldosterone-producing cells to disappear. Researchers predicted prolonged inhibitor treatment might have a similar effect in humans.


Morris Brown, lead author and professor of endocrine hypertension at Queen Mary, said, &quot;While duly cautious about our findings because of the pragmatic nature of the study, they were predicted by previous experiments, and longer follow-up may justify a claim that a finite course of medication leads to infinite cure. EASI treatment is unlikely to be the elixir for most patients with hypertension. But the possibility of tablets achieving a surgical cure has long been a holy grail for this common type of hypertension.&quot; Mason Freeman, professor of medicine at Harvard Medical School and initiator of the original study, said the follow-up generated &quot;extraordinary and unexpected findings&quot; offering &quot;the very exciting possibility that many patients with primary aldosteronism may be able to be treated with a once-a-day pill, perhaps for a limited period of time, and obtain similar benefits to what we now achieve only after invasive diagnostic testing and major adrenal surgery.&quot;


In the United Kingdom, the drug is being assessed by the National Institute for Health and Care Excellence (NICE). Building on these findings, researchers are now leading a larger prospective clinical trial called ELIXIR to investigate whether EASI treatment can provide a lasting cure and will use molecular imaging to study whether prolonged treatment causes aldosterone-producing cells to disappear.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Open Access Government | Novel drug therapy may cure common hormonal cause of high blood pressure | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxPMnRpYVdzUTl3WEduMHdTc1V3eHNHeTkwRVdZV3JrUGM0S2pYVUxLN1pTa080V3pNekR1X1BOak55NTh0ckNrRmlCSzlydWhyaUJ2NWFDeDA4M1dxWWUwZ01qdmVUa0xJMXlfRzk5Vzcxa0V4ZXFFZWo3TWdjdG1PRTRXM3JKWURXcm1vLUxGeVkyRXZlLXA2bk8zN3A2ZnlsdmRXdlYzdnZFWWZybjFBWlNiUVJOeFVM?oc=5) |
| The Sun | New high blood pressure pill that ‘cures’ the condition could be available in 2027 | [Source Link](https://news.google.com/rss/articles/CBMiiAFBVV95cUxNWV9KVjFkczBreVNUQnktVmZwa0cwcUxpQlRFdTRPdHVZVkR4VTdwZ1NOV2luRXBibmlyeUp1clBxaGRPTmVqYzV5RlVzenN1LURIUGJ0WXdJTFVWX2pIQUtobldLUjEwaklIUGM4eXRSQ0ZvMElIbTRGdkF3MklFa19Vdzdra2h2?oc=5) |
| Kalkine Media | Pharma stocks: Why AstraZeneca (LSE:AZN) is setting the tone for UK healthcare | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxQZEZCM2FMTnVjQWNaVUtXVDlyZVlnU215Y2NfT3loakx4YUZEYlFfOWx0MXl3MzJyTXFMOGNUa2tsZXd1S05NQkh1RlZsbTFNQmk5dEd2TmJTVkNUQUxJTDBpWC1EU3F4dHBrUXhpZkFWWGhnU1A2bDBXUGlTN2p6MkhjNjNkemJRRjFEUkRNSXJxNC02eHF4RWVtVldfVDIxNzRUc3BqYzhvZFdSRlV6TmxqaVQxTzN6UjlEMQ?oc=5) |
| The i Paper | New drug that could permanently cure high blood pressure coming to UK by 2027 | [Source Link](https://news.google.com/rss/articles/CBMidkFVX3lxTE82ZGZKdG82RGs1ZTdhVzU4S1BsWUtjdmZMUmNkbllFcDJfVk5mb3IzYkVybmJQOFd1UnpBWi1rcnBfeUJPdDBZaWx3a1hTN1RzZV9HRDdkNXBuaW1LU21GazBscnJKd2J0ekxua0NSU0VWZFd2a0E?oc=5) |
| Kalkine Media | Pharma stocks: Why baxdrostat matters for AstraZeneca (LSE:AZN) | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxOejdWMWV2RU5aOE5iZEp0WXRmUDRWV3hJQzRUZkFUNjk2bHMzMVFzaURmM2RYS1VqUmhhWXdqNmJydTBDN096NzhEUm9FMXNIQWQyX05WWG1mMTFTalVCSlAwcldSX01UamNDaXRfelZUSFZHbVA4WDVVRjNQSnlpTWpLMHlubEMyako4Yi1MSU5TTVBTaWhyTkJmb2NPNV83d3pDdmhR?oc=5) |
| UA.NEWS | Baxdrostat’s effect persisted for up to two years after treatment — The Guardian | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxQYkRpbmhaQnBWbkNxNFktQVhJblFqOUNjWENsQmI2TExnVlRzaThoRkl1X2VnNDNjNmp4WnZaTUoyaU9OUHFjRkJXZEdLa3E1RUNteWNIam1vQndGX3pIRzY0VWh5eFA3WHVibzFHS0JVMkpRa0hHRWFHZDY4SW9Tc3pUMkZPNjdvVXdFV1paSGFKRXZySEV2RnQ2RS0zdzRscnZQUTJRZ1lqSzhXSnc?oc=5) |
| The Guardian | New drug could be cure for common cause of high blood pressure | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxNdkUyODdxU2lpWjdmdm0taE1KLWJmVlZrR2RKc3N4aEpzbXZwYnF4dVdwMlp5QWQ3SzY0Qk5nVlB6TktseEpHOGJIX0ZRZGY5ODJ6Nm1yZ1gzTXo1WTliSzRiMmVfV1JOcHZrLTNsTjk1ZHFTZEF5WnJoSFBINlZaZFVXcVMtN3JrMzN0Ynh0RUc?oc=5) |
| Medical Xpress | New treatment may cure common hormonal cause of high blood pressure | [Source Link](https://news.google.com/rss/articles/CBMihwFBVV95cUxQdDEtSF9vaFhBVy0xYzRWREp4U2xrbndTYnE2VDB1SzAtN0w1LUtyd0pzZlRmbmhhdk9CbHFfc2g5cjF0UVIzTW5NZEs2TEdoaXR5STlhY2RncnFTWnRzendhOTFjTGtNS3hhSWR4ZDVtZ2g3cGMwZjdsZGJvOU9hWWFUZW9obU0?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-11-08/new-treatment-may-cure-common-hormonal-cause-of-high-blood-pressure*
